YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) Comparison with companies in other sectors?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has a share price of 1.17B. You can analyze YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) competitors across different market sectors through stock heatmaps.

What are YIHCF's NET and operating margins?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) operating margin is around 0.33, and net profit margin is approximately 0.30 as of the latest reports.

In what way does YIHCF's earnings per share (EPS) trend reflect its financial momentum?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) EPS is -0.11 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is -5.00, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for YiChang HEC ChangJiang Pharmaceutical Co., Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for YiChang HEC ChangJiang Pharmaceutical Co., Ltd. like P/E which is 2.11, P/B which is 0.41, and PEG which is -0.02. Compare them with sector averages to evaluate if the stock is priced fairly.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

YIHCF•PNK

Healthcare

Drug Manufacturers - Specialty & Generic

$0.55

$0.00(0.00%)

Fundamental Analysis of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.11

P/E Ratio

-5.00

ROE

0.19%

Net Margin

0.30%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$643.13M

Shares OutstandingTotal number of shares issued

$1.17B

Book Value/ShareNet worth per share

$9.67

Revenue/ShareAnnual revenue per share

$6.30

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.11

Net MarginNet income as percentage of revenue

29.74%

Operating MarginOperating income as percentage of revenue

32.91%

ROEReturn on shareholders' equity

19.19%

ROAReturn on total assets

13.26%

ROCEReturn on capital employed

19.02%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.09

Cash/ShareCash and equivalents per share

$1.60

FCF YieldFree cash flow as percentage of market cap

-1.67%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for YIHCFFinancial Ratios Analysis details for YIHCF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for YIHCFSector Benchmarking details for YIHCF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of YiChang HEC ChangJiang Pharmaceutical Co., Ltd.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s unique business strengths and challenges.

Key Financial Metrics for YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

For YiChang HEC ChangJiang Pharmaceutical Co., Ltd., essential financial indicators include EPS -0.11, PE -5.00, and ROE 0.19. These key ratios reveal insights into YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare YiChang HEC ChangJiang Pharmaceutical Co., Ltd. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Metrics like Net Margin 29.74% and ROA 13.26% shed light on how well YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether YiChang HEC ChangJiang Pharmaceutical Co., Ltd. can sustain its operations and continue growing in the future.

Valuation and Market Position of YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Using ratios such as P/B Ratio 0.41 and PEG Ratio -0.02, investors can assess whether YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is appropriately valued based on its financials and growth potential. These figures, combined with YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Financial health indicators, such as Debt/Equity Ratio 0.26 and Cash Flow $-0.09, provide a snapshot of YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like YiChang HEC ChangJiang Pharmaceutical Co., Ltd., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Investing in YiChang HEC ChangJiang Pharmaceutical Co., Ltd. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at YiChang HEC ChangJiang Pharmaceutical Co., Ltd. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;